Synonyms: Dipeptide 9f [PMID 19175320] | GAP-134 | ZP-123
Compound class:
Peptide
Comment: Rotigaptide is a hexapeptide developed originally by Wyeth, as an anti-arrhythmic agent. It promotes electrical coupling between ventricular myocytes by increasing gap junction conductance [1]. A recent study showed reduction in myocardial infarction size in a porcine model and protection from IRI-related endothelial dysfunction in man. Rotigaptide may thus have therapeutic potential in the treatment of myocardial infarction [2].
|
Bioactivity Comments |
Promotes electrical coupling between ventricular myocytes by increasing gap junction conductance potentially via alterations in the phosphorylation status of Cx43 (Gap junction alpha-1 protein GJA1, P17302) but the exact mechanism is unknown. |